Pfizer CEO says company to submit data on COVID-19 vaccine trial in children aged 5 to 11 within days, as U.S. daily death toll remains above 2,000
September 27, 2021 at 10:17 AM EDT
The chief executive of Pfizer Inc. said the company is expecting to submit data from late-stage trials of its COVID-19 vaccine in children ages 5 to 11 to the U.S. Food and Drug Administration within days, raising hopes that another key patient group will soon be eligible for shots.
